CanSino Biologics Inc. (OTCMKTS:CASBF) Sees Large Decline in Short Interest

CanSino Biologics Inc. (OTCMKTS:CASBF) was the target of a significant decline in short interest in February. As of February 15th, there was short interest totalling 10,800 shares, a decline of 19.4% from the January 31st total of 13,400 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

CanSino Biologics Trading Down 3.6 %

Shares of CanSino Biologics stock opened at C$4.72 on Thursday. The company’s 50-day moving average price is C$3.64 and its two-hundred day moving average price is C$3.40. CanSino Biologics has a 52 week low of C$1.86 and a 52 week high of C$4.90.

About CanSino Biologics

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.